Drug Type Synthetic peptide |
Synonyms CD4M9 |
Target |
Action inhibitors |
Mechanism CD4 inhibitors(T-cell surface antigen CD4 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HIV Infections | Preclinical | France | 09 Nov 1999 |






